Results 51 to 60 of about 2,128 (111)

Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin. [PDF]

Nat Commun
Fouillen A, Bous J, Couvineau P, Orcel H, Mary C, Lafleur L, Pierre T, Mendre C, Gilles N, Schulte G, Granier S, Mouillac B.   +11 more
europepmc   +1 more source

Recent Clinical and Molecular Advances in the Management of Thymic Carcinoids: A Comprehensive Review. [PDF]

Cancers (Basel)
Piórek A, Płużański A, Kowalski DM, Krzakowski M.   +3 more
europepmc   +1 more source

Central and nephrogenic diabetes insipidus: updates on diagnosis and management. [PDF]

Front Endocrinol (Lausanne)
Flynn K, Hatfield J, Brown K, Vietor N, Hoang T.   +4 more
europepmc   +1 more source

Association between <i>CYP2C19</i> polymorphism and proton pump inhibitors adverse drug reactions: a narrative review. [PDF]

Front Pharmacol
Ibrahim A, Yusuff K, Awaisu A, Elewa H.
europepmc   +1 more source

From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections. [PDF]

Rev Endocr Metab Disord
Sarmento-Cabral A, Fuentes-Fayos AC, Ordoñez FM, León-González AJ, Martínez-Fuentes AJ, Gahete MD, Luque RM.   +6 more
europepmc   +1 more source

Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function. [PDF]

Clin Sci (Lond)
Couvineau P, Llorens-Cortes C.
europepmc   +1 more source

Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH. [PDF]

Front Endocrinol (Lausanne)
Menzi S, Jaramillo SD, Pfister S, Schefer H, Jehle AW.   +4 more
europepmc   +1 more source

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis. [PDF]

J Transl Med
Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA.   +14 more
europepmc   +1 more source

Vortioxetine-induced syndrome of inappropriate secretion of antidiuretic hormone: A case report. [PDF]

Neuropsychopharmacol Rep
Sasaki T, Shindo Y, Kikuchi K, Kawamata Y, Sugawara N, Yasui-Furukori N.   +5 more
europepmc   +1 more source

Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series. [PDF]

CEN Case Rep
Nishida J, Yamakawa M, Miura S, Yasutomi M.   +3 more
europepmc   +1 more source